Simvastatin Evokes An Unpredicted Antagonism For Tamoxifen In MCF-7 Breast Cancer Cells.
Amel B IbrahimHala F ZakiWalaa WadieMervat M OmranSamia A ShoumanPublished in: Cancer management and research (2019)
Although the combination regimen of TAM and SIM showed an antagonistic drug interaction in MCF-7 breast cancer, it displayed favorable antiangiogenic, anti-metastatic, and anti-inflammatory effects.